There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Glythera gains exclusive access to Cancer Research UK’s novel CDK11 inhibitor program for the development of ADCs conjugated using its highly stable conjugation platform, PermaLink.

Glythera Licenses Novel Payload Class from Cancer Research UK for ADC Development

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Biopharmaceutical companies developing new competitive biotech therapies have pressed hard for clarity on the testing and data required by FDA to gain market approval of biosimilars that can be filled by a pharmacist without prescriber preapproval. 

Will Interchangeability Boost Biosimilar Prescribing?

Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.

Ajinomoto Althea Adds High Potency Capabilities

The collaboration with Immunocore, a T cell receptor company, aims to discover and develop immunotherapy molecules to treat infectious diseases.

Gates Foundation Invests $40 Million in Immunotherapy Collaboration

The approval marks the first biosimilar approved in the United States for treating cancers.

FDA Approves Amgen’s Avastin Biosimilar

European Medicines Agency’s Committee for Medicinal Products for Human Use grants a positive opinion for the approval of the biosimilar for treating breast cancer.

EMA Recommends Approval of Herceptin Biosimilar

The new building is protected by special construction against vibration to ensure accurate calibration of laboratory balances. 

Sartorius Opens New Manufacturing Facility for Lab Instruments

The company has extended its presence in the US market to support its growing business in the region.

Oxford Genetics Opens First US Office

Merck KGaA completes the divestment of its biosimilars business as part of its strategy to focus on developing a pipeline of innovator drugs.

Merck KGaA Completes $788-Million Divestment of Biosimilars Business

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Technology improvements in analytical testing tools have helped increase understanding of molecules and speed up development processes.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes